AI Stock Picks — S&P 500

Wednesday, October 21, 2026  ·  Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days

Today's Market Mood

Neutral  Normal choppiness · VIX 16.6

The index shows a sharp sector rotation: AI/semiconductor and high-multiple growth names (NVDA, AMD, MU, AMAT, KLAC, LRCX, ORCL, INTC) are down double digits over 30 days, while healthcare, energy, travel/leisure and select financials/industrials are staging strong recovery rallies with 5-day and 30-day returns both positive. Most rally candidates remain meaningfully below their 52-week highs, suggesting this is an oversold bounce/rotation rather than a fresh broad bull leg, so near-term upside is plausible but not guaranteed to persist.

Rotation out of AI/semiconductor momentum names into defensives and healthcareEnergy complex (crude refiners, E&Ps, majors) rallying on firmer oil pricesHealthcare/managed-care and pharma broadly recovering after a prolonged drawdownTravel and leisure (hotels, cruise-adjacent) showing renewed strength into year-end booking season

Today's Actionable List

Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.

0 of 4
0%
77 · 125.4%
125.4% / 60%
0 of 20
RankStockActionSizeEntry → TargetNotes
#1 BDX SKIP — $195.09 → $205.32
stop $181.04
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#2 RSG SKIP — $230.67 → $242.78
stop $216.37
 Position cap reached — 77 of 20 slots in use.
#3 VTRS SKIP — $18.58 → $19.58
stop $17.26
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#4 EOG SKIP — $157.70 → $166.37
stop $146.66
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.

Already open: LGEN.L (to Oct 21), SSE.L (to Oct 21), AAPL (to Oct 22), KGF.L (to Oct 23), DCC.L (to Oct 25), DPLM.L (to Oct 28), EMR (to Nov 1), ALW.L (to Nov 1), PSN.L (to Nov 1), MSFT (to Nov 4), ADI (to Nov 4), SVT.L (to Nov 5) … and 65 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.

Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.

Behind the scenes: how each AI analyst did
Aria
8 picks
Blaze
7 picks
Nova
3 picks
Orion
4 picks
Quinn
6 picks

4 Stock Picks

Sector concentration cap applied: 1 lower-ranked pick removed to keep at most 2 picks per sector (ELV), so the final list isn't over-concentrated in one sector.
#1 BDXBecton, Dickinson and Company
5/5 Agents Agree  Risk 5/10  ⚠ Conflicting Signals  ⚠ Earnings in Window
Moderate conviction · 55%

Becton, Dickinson makes medical devices and lab equipment used in hospitals worldwide. The stock is in a healthy uptrend, beating the market comfortably without yet looking overheated. Earnings arrive within the holding window and some executives have been selling shares, both worth keeping an eye on.

Stop-loss$181.04-7.2%
Today's price$195.09
Target$205.32+5.2%
Agents estimate: $205.80 (+0.2% vs target)
If you invested $1,000
▲$1,052 if the target hits (+5.2%)
▼$928 if the stop-loss is hit (-7.2%)
The AI puts the chance of the win case at 55%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Price ($195.09) is almost touching the upper Bollinger Band ($196.30), leaving only ~0.6% of room before technical resistance kicks in — most of the move needed for a 5% target may already be spent.
  • OBV sits at -47.2M even as price rallied 7.9% over 30 days — cumulative volume flow is net negative, meaning the advance isn't being driven by strong accumulation despite the price strength.
Show the detailed analysis

Calibrated probability: 55% (raw model estimate: 63%) — adjusted using the accuracy of past resolved picks.

Trade math

0.7:1
58%
+0.6%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
56%
Medium
Nova
58%
Medium
Orion
66%
High
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#2 RSGRepublic Services, Inc.
4/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals  ⚠ Earnings in Window
Moderate conviction · 55%

Republic Services collects and manages waste and recycling across the country. Its stock has been outperforming the broader market over the past month, and notably, a major outside investor (Cascade Investment, tied to Bill Gates) has been buying well over a billion dollars of shares recently, a strong vote of confidence. The main risk is that the company reports earnings within our 30-day window, which could swing the price in either direction.

Stop-loss$216.37-6.2%
Today's price$230.67
Target$242.78+5.3%
Agents estimate: $243.35 (+0.2% vs target)
If you invested $1,000
▲$1,053 if the target hits (+5.3%)
▼$938 if the stop-loss is hit (-6.2%)
The AI puts the chance of the win case at 55%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Price ($230.67) is extended roughly 5.2% above its 50-day SMA ($219.32), and is pressed against the upper Bollinger Band ($234.66) — a classic setup for mean reversion rather than continuation.
  • OBV reads -30.3M despite the 7.8% rally, meaning net volume flow has been negative even as price climbed — the move looks more price-driven than volume-confirmed.
Show the detailed analysis

Calibrated probability: 55% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.

Trade math

0.8:1
54%
+1.4%
8.5%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
72%
Very High
Nova
—
—
No stock-specific news catalyst found; a large holder's recent buying is a positive sign but isn't a time-bound catalyst, and earnings arrive in 8 days.
Orion
56%
Medium
Quinn
62%
High

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#3 VTRSViatris Inc.
4/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals  ⚠ Earnings in Window
Moderate conviction · 55%

Viatris makes generic and branded medicines sold around the world. The stock has been climbing steadily and beating the market, likely reflecting renewed confidence in its turnaround plan. Because it's a lower-priced stock, it can move more sharply on news, and it reports earnings within our 30-day window.

Stop-loss$17.26-7.1%
Today's price$18.58
Target$19.58+5.4%
Agents estimate: $19.65 (+0.4% vs target)
If you invested $1,000
▲$1,054 if the target hits (+5.4%)
▼$929 if the stop-loss is hit (-7.1%)
The AI puts the chance of the win case at 55%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • At $18.58, price is within 0.75% of the upper Bollinger Band ($18.72) — very little technical headroom remains before resistance, especially on a sub-$20 stock where ATR of $0.48 (~2.6% of price) means normal volatility alone could stall the move.
  • The 8.7% 30-day gain is itself unusually large for a low-priced, slow-growth generics name — a reversion toward the $17.84 Bollinger midline would erase most of the recent gain.
Show the detailed analysis

Calibrated probability: 55% (raw model estimate: 68%) — adjusted using the accuracy of past resolved picks.

Trade math

0.8:1
57%
+1.4%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
69%
High
Nova
—
—
Orion
66%
High
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#4 EOGEOG Resources, Inc.
3/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals  ⚠ Earnings in Window
Moderate conviction · 55%

EOG Resources is one of the largest U.S. oil and natural gas producers. Its shares are rallying as energy stocks stage a comeback, and the stock is outpacing the broader market by a wide margin. The main risks are swings in oil and gas prices and an earnings report due within the holding period.

Stop-loss$146.66-7.0%
Today's price$157.70
Target$166.37+5.5%
Agents estimate: $167.16 (+0.5% vs target)
If you invested $1,000
▲$1,055 if the target hits (+5.5%)
▼$930 if the stop-loss is hit (-7.0%)
The AI puts the chance of the win case at 55%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • RSI at 68.96 is a hair below the conventional overbought line of 70 — the thesis frames this as 'not yet overbought,' but it leaves almost no cushion before momentum indicators flip bearish.
  • 5-day momentum (+2.27% price / +3.9% history-based) is running well below the 30-day pace (+11.6%), indicating the rally is decelerating even as the headline return looks strong.
Show the detailed analysis

Calibrated probability: 55% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.

Trade math

0.8:1
56%
+1.4%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
—
—
Nova
—
—
Orion
66%
High
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha

Retail Investor Execution Guide

This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by November 20, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.

Step-by-Step Action Plan

  1. Act within one trading day. Prices are freshest now. The longer you wait, the more the entry price drifts away from what the agents analysed.
  2. Verify the entry price. Check the live price before buying. If a stock has already moved more than 3% above the Current Price shown in the report, skip it or wait for a pullback — the risk/reward has shifted.
  3. Use limit orders, not market orders. Set your buy limit at or below the Current Price shown. Chasing with a market order gives brokers and algorithms an advantage over you.
  4. Set your stop-loss immediately after buying. Use the Max Downside % on each pick card as your hard exit level. If the price falls to that level, sell without hesitation — the trade thesis is broken.
  5. Set a take-profit at the Target Price. Place a limit sell order at the Target Price shown. When it fills, the trade is done — resist the urge to hold for more.
  6. Exit all positions by November 20, 2026. This is your hard deadline. If a stock has not hit its target by then, exit anyway. Holding past the window turns a short-term trade into an unsupervised long-term position.
  7. Never add to a losing position. If your stop-loss is hit, exit completely. Averaging down turns a small, controlled loss into a potentially large one.

Position Sizing by Conviction Tier

Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.

Agents Agreeing What It Means Max Allocation Per Pick
5/5 Highest conviction — all five independent analytical checks passed Up to 10%
4/5 Very high conviction — four of five independent checks aligned Up to 8%
3/5 High conviction — three agents independently agreed Up to 6%
2/5 Moderate conviction — two agents independently agreed Up to 4%
1 Agent Speculative — solo pick, admitted only at Very High confidence Up to 2%

The Three Exit Rules

These picks are generated by AI agents for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Probability estimates reflect the agents' analytical models — they are not guarantees of any outcome. Past results are not indicative of future performance. Markets can and do move against even well-researched trades. Always conduct your own research, and consider seeking advice from a licensed financial adviser before placing any orders. Never invest money you cannot afford to lose.

Understanding the Numbers

A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.

AI Conviction Meter
Estimated probability of hitting the target, shown as a 5-bar gauge
The filled bars and label translate the AI's probability estimate into plain language: 75%+ is Very strong, 60–74% Strong, 50–59% Moderate, below 50% Cautious. Where enough past picks have been resolved, the probability is calibrated against the AI's real track record.
e.g. "Moderate conviction · 58%" — the AI thinks this trade works slightly more often than a coin flip.
✓ More filled bars = more confidence — but even Very strong picks fail sometimes; always size positions accordingly.
If You Invested $1,000
$1,000 × (1 + Target Gain ÷ 100)  /  $1,000 × (1 + Max Downside ÷ 100)
The same Target Gain and Max Downside percentages expressed in concrete money terms for a $1,000 position — what you'd have if the target hits versus if your stop-loss is triggered.
e.g. +10% target and −12.3% stop → $1,100 on a win, $877 on a stopped-out loss.
✓ Scales linearly — a $500 position sees half these amounts, a $2,000 position double.
Current Price
Market price at time of analysis
The stock's price when this report was generated. All other figures on the card are calculated from this reference point.
e.g. $215.20 — check the live price before placing an order; if it has moved more than ~3%, re-evaluate the risk/reward.
✓ No positive/negative distinction — it is simply your cost basis.
Target Price
Current Price × (1 + Target Gain ÷ 100)
The price the agents project the stock could reach within the time window. This is your take-profit level — place a limit sell order here after buying.
e.g. $215.20 × 1.085 = $233.49 target on an 8.5% pick.
✓ Always above Current Price — this tool only selects upside candidates.
Target Gain
(Target Price − Current Price) ÷ Current Price × 100
The percentage return you would earn if the stock hits its Target Price from your entry. Set by the run parameters — every pick in this report targets the same percentage.
e.g. +8.5% means a $100 stock has a $108.50 target; a $500 stock has a $542.50 target.
✓ Always positive — picks are upside-only. A larger % means a bigger move is required.
Max Downside
Estimated stop-loss level, as % below entry
The worst-case loss the agents estimated if the thesis fails — based on key support levels and recent volatility. Use this as your hard stop-loss. If the price falls to this level, exit immediately; the trade thesis is broken.
e.g. −12.0% means: if you bought at $100, sell if it drops to $88.00.
⚠ Always negative. A smaller magnitude (e.g. −5%) = tighter risk. A larger magnitude (e.g. −20%) = more room to fall before you exit — riskier.
Reward : Risk
Target Gain ÷ |Max Downside|
How much you could gain for every dollar you are risking. A ratio of 2.0:1 means you stand to make $2 for every $1 at risk. Higher is better.
e.g. 8.5% gain ÷ 12% downside = 0.7:1 (unfavourable). 10% gain ÷ 5% downside = 2.0:1 (good).
✓ ≥ 2.0:1 is strong. ⚠ < 1.0:1 means you are risking more than you could gain — approach with caution.
Breakeven Win Rate
|Max Downside| ÷ (Target Gain + |Max Downside|) × 100
The minimum percentage of trades at this reward:risk that must succeed for you to break even over time — regardless of how good your stock picking is.
e.g. 12 ÷ (8.5 + 12) = 59% — you need roughly 6 in 10 trades to win just to avoid losing money.
✓ Lower is better — ≤ 35% means even a poor win rate is survivable. ⚠ ≥ 55% means you need most trades to work out.
Expected Value
(Probability% × Target Gain%) + ((1 − Probability%) × Max Downside%)
The average return per trade if the AI's probability estimate is accurate over many similar trades. A positive Expected Value means the trade has a mathematical edge; a negative value means the math works against you on average, even if you sometimes win.
e.g. 65% × +8.5% + 35% × −12% = +1.3% EV. Over 100 similar trades you would expect an average gain of 1.3% per trade.
✓ Positive = edge in your favour over many trades. ⚠ Negative = the math loses money on average — even if individual wins feel good. Note: EV is only as reliable as the probability estimate.
Suggested Allocation
half-Kelly: (Probability ÷ |Max Downside| − (1 − Probability) ÷ Target Gain) ÷ 2, capped at 10%
The Kelly criterion computes the portfolio fraction that maximises long-run growth for a bet with these odds; half-Kelly is the standard hedge against the probability estimate being too optimistic. Uses the calibrated probability where available. 0% means the math sees no edge worth sizing; — means it couldn't be computed.
e.g. 57% probability, +10% target, −13% downside → Kelly ≈ 8.5% of portfolio, half-Kelly ≈ 4.2%.
Generic sizing guidance only — not personal investment advice. Position sizing must reflect your own portfolio, risk tolerance and circumstances.
Every stock Scout considered — and why each was discarded

Scout scanned 503 S&P 500 constituents and short-listed 29 candidates for deep analysis by the five analysts. Here is what happened to each one.

  • FDSFactSet Research Systems Inc.Dropped at merge
    Scout: Strong 10.3% 5-day and 12.5% 30-day gains with price only 0.3% off its 52-week high, signaling confirmed breakout momentum.
    Qualified on merit but ranked #7, outside the 5-pick limit for this run.
  • WSTWest Pharmaceutical Services, Inc.Liquidity filter
    Scout: Consistent acceleration (5.5%/9.2% over 5d/30d) and within 0.2% of its 52-week high, a healthy continuation setup.
    20-day average daily volume 487,149 shares is below the 500,000-share liquidity floor.
  • BDXBecton, Dickinson and CompanyPicked #1
    Scout: Positive momentum across both windows and essentially at its 52-week high, indicating a durable uptrend.
    Made the final report at #1.
  • VEEVVeeva Systems Inc.Dropped at merge
    Scout: 22% 30-day return with accelerating 5-day gains and just 1.2% from its 52-week high, among the strongest momentum names in the index.
    Qualified on merit but ranked #8, outside the 5-pick limit for this run.
  • HASHasbro, Inc.Passed over
    Scout: Explosive 17.5%/27.9% 5d/30d returns and near its 52-week high, consistent with a sustained post-catalyst rally.
    Aria: The rally was driven almost entirely by one huge earnings-beat day that already happened, RSI is extremely overbought (near 85), and multiple insiders have been selling — the move looks largely exhausted.
    Blaze: Already surged 28% in 30 days with RSI near 85 right after a massive earnings beat — looks fully priced in and overbought, not fresh upside
    Nova: Despite a huge earnings beat yesterday, the stock has already rallied 28% in a month and its RSI is near 85 — an extremely overbought reading that raises the risk of a pullback rather than further gains.
    Quinn: Already jumped nearly 28% with RSI at 85, deep into overbought territory, making a near-term pullback more likely than a further 5% advance
  • CDWCDW CorporationDropped at merge
    Scout: Steady 5%/7.7% gains over 5d/30d with price just 2% below its 52-week high.
    Qualified on merit but ranked #6, outside the 5-pick limit for this run.
  • LLYEli Lilly and CompanyAlready held
    Scout: Leading the pharma rally with 5.1%/9.1% 5d/30d returns and only 3% off its 52-week high.
    Already held: a position opened 2026-10-16 runs until 2026-11-15 (25 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • AMGNAmgen Inc.Already held
    Scout: 11.2% 30-day return with price just 2.2% below its 52-week high, part of a broad biopharma recovery.
    Already held: a position opened 2026-10-15 runs until 2026-11-14 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • TMOThermo Fisher Scientific Inc.Dropped at merge
    Scout: Consistent gains near its 52-week high, reflecting renewed strength in life-sciences tools names.
    Only Nova selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: High, 65% raw (55% after calibration)).
  • UNHUnitedHealth Group IncorporatedAlready held
    Scout: Strong 5.5%/10.5% 5d/30d rebound in managed care after a prolonged selloff.
    Already held: a position opened 2026-10-15 runs until 2026-11-14 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CIThe Cigna GroupAlready held
    Scout: 5.7%/11.5% 5d/30d gains and within 1.7% of its 52-week high, confirming managed-care sector strength.
    Already held: a position opened 2026-10-19 runs until 2026-11-18 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ELVElevance Health, Inc.Passed over
    Scout: 7.7% 30-day gain and only 2.2% below its 52-week high, tracking the broader healthcare rotation.
    Orion: Reports earnings today, adding immediate event risk, and is already overbought (RSI ~73) after a strong run.
    Quinn: Reports earnings today, meaning the recent 7.7% gain already prices in that event, adding uncertainty rather than clean momentum support
  • CAHCardinal Health, Inc.Passed over
    Scout: 14.1% 30-day return with price just 0.6% off its 52-week high, among the strongest healthcare distributors.
    Aria: Decent momentum, but heavy insider selling (including a large CEO sale) and earnings due within the holding window made it less attractive than our top picks.
    Blaze: Catalyst is over two months old, the CEO alone sold about $29 million in stock, and earnings fall inside the holding window
    Nova: No stock-specific catalyst confirmed; the news found was generic market commentary, not anything specific to Cardinal Health.
    Orion: The most overbought name evaluated (RSI ~75) after a 14% rally; healthcare is already represented by stronger-setup picks.
    Quinn: RSI at 75 is at the edge of overbought, and heavy recent insider selling reduces confidence in further upside
  • MCKMcKesson CorporationPassed over
    Scout: 14.5% 30-day gain near its 52-week high, consistent sector tailwind.
    Aria: Solid uptrend, but earnings fall within the 30-day window after an already sharp run-up, so it ranked below cleaner setups.
    Blaze: No detailed earnings-release text was available to confirm a fresh catalyst, and earnings fall within the holding window after a near-15% monthly run-up
    Nova: No confirmed recent catalyst; gains look driven by the same healthcare sector rotation rather than a McKesson-specific event.
    Orion: Has already pulled back from its own recent high and remains very overbought (RSI ~73), a less attractive entry than other healthcare names.
  • VTRSViatris Inc.Picked #3
    Scout: 6.5%/8.7% 5d/30d gains, under 1% from its 52-week high — a smaller-cap pharma name with confirmed momentum.
    Made the final report at #3.
  • VVisa Inc.Passed over
    Scout: 4.4%/10.5% 5d/30d gains with price essentially at its 52-week high, a payments-sector leader.
    Aria: Momentum is strong, but the stock is overbought (RSI over 75) and reports earnings in less than a week, a risky combination.
    Blaze: Earnings arrive in just 6 days, RSI is above 76, and insiders including the CEO have been selling — too much stacked risk on an already extended stock
    Nova: No recent catalyst found, and earnings arrive in just 6 days, adding pre-earnings uncertainty without a clear reason to expect a positive surprise.
    Orion: Overbought (RSI ~77), already near its 52-week high, and reports earnings in under a week, limiting margin of safety.
  • MAMastercard IncorporatedAlready held
    Scout: 9.8% 30-day gain and just 0.2% off its 52-week high, mirroring Visa's strength.
    Already held: a position opened 2026-10-13 runs until 2026-11-12 (23 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • BRK-BBerkshire Hathaway Inc.Passed over
    Scout: 8% 30-day return and only 0.3% below its 52-week high, broad market-leading stability with upside.
    Aria: Overbought conditions plus a large recent insider sale reduced our confidence in this momentum play.
    Blaze: Most of the reported earnings growth came from investment gains rather than operating performance, and RSI above 80 suggests the stock is very extended
    Orion: Extremely overbought (RSI ~80); financials sector tailwind is only partially confirmed, weakening conviction.
    Quinn: RSI at 80.3 signals an overextended short-term move, increasing the odds of a pause rather than further gains
  • MRSHMarsh & McLennan Companies, Inc.Already held
    Scout: 6.3%/9.8% 5d/30d gains and close to its 52-week high in a resilient insurance-brokerage segment.
    Already held: a position opened 2026-10-19 runs until 2026-11-18 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ADPAutomatic Data Processing, Inc.Already held
    Scout: 9% 30-day gain with price just 0.6% off its 52-week high, a steady compounder regaining strength.
    Already held: a position opened 2026-10-19 runs until 2026-11-18 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CTASCintas CorporationDropped at merge
    Scout: 11.8% 30-day return essentially at its 52-week high, confirming a durable uptrend.
    Only Blaze selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: Very High, 83% raw (67% after calibration)).
  • RSGRepublic Services, Inc.Picked #2
    Scout: 7.8% 30-day gain and just 1.2% off its 52-week high in a defensive, low-volatility sector.
    Made the final report at #2.
  • IFFInternational Flavors & Fragrances Inc.Dropped at merge
    Scout: 8.7% 30-day gain and only 1.3% below its 52-week high, signaling renewed specialty-chemicals strength.
    Only Quinn selected this stock — Quinn solo picks require High or Very High confidence and at least 60% probability (this pick: Medium, 60% raw (55% after calibration)).
  • CVXChevron CorporationAlready held
    Scout: 11.3% 30-day gain with price just 0.3% off its 52-week high as crude strengthens.
    Already held: a position opened 2026-10-20 runs until 2026-11-19 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • XOMExxonMobil Holdings CorporationAlready held
    Scout: 12.3% 30-day return and only 1.4% from its 52-week high, leading the energy complex higher.
    Already held: a position opened 2026-10-16 runs until 2026-11-15 (25 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • COPConocoPhillipsAlready held
    Scout: 14.4% 30-day gain with price under 1% from its 52-week high, confirming the E&P rally.
    Already held: a position opened 2026-10-13 runs until 2026-11-12 (23 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • EOGEOG Resources, Inc.Picked #4
    Scout: 11.5% 30-day gain and only 1.4% off its 52-week high, tracking the broader energy upswing.
    Made the final report at #4.
  • MARMarriott International, Inc.Already held
    Scout: 9.2%/18.5% 5d/30d gains and just 1.2% below its 52-week high, indicating strong travel-sector demand.
    Already held: a position opened 2026-10-19 runs until 2026-11-18 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • HLTHilton Worldwide Holdings Inc.Passed over
    Scout: 10.6%/18.2% 5d/30d gains near its 52-week high, confirming continued hospitality-sector strength.
    Aria: Very overbought (RSI over 80) heading into earnings next week, raising the odds of a pullback before any further gain.
    Nova: Strong recent momentum, but an RSI near 81 signals extreme overbought conditions, and earnings in 6 days adds binary risk on top of an already-extended move.
    Orion: Extremely overbought (RSI ~81) after an 18% rally and reports earnings within the holding window, raising two-sided risk.
    Quinn: RSI at 80.6 after an 18% one-month gain suggests the move is already extended, raising reversal risk

Agent Analytical Approaches

Aria

Momentum & Technical

Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.

Blaze

Fundamental & Earnings

Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).

Nova

News Catalyst & Event-Driven

Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.

Orion

Macro & Sector Rotation

Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.

Sage

Devil's Advocate

Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.

Quinn

Quantitative / Statistical

Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.